Avacta Group Plc (LON:AVCT – Get Free Report) fell 8.4% on Monday . The company traded as low as GBX 43.28 ($0.55) and last traded at GBX 43.50 ($0.55). 836,913 shares were traded during trading, a decline of 66% from the average session volume of 2,461,108 shares. The stock had previously closed at GBX 47.50 ($0.60).
Avacta Group Price Performance
The stock has a 50 day simple moving average of GBX 44.03 and a two-hundred day simple moving average of GBX 73.04. The company has a market cap of £156.19 million, a price-to-earnings ratio of -527.78 and a beta of 1.22. The company has a debt-to-equity ratio of 191.87, a current ratio of 0.62 and a quick ratio of 4.96.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
See Also
- Five stocks we like better than Avacta Group
- What is a Special Dividend?
- Micron Technology Stock Volatile Despite Analyst Upgrades
- How to Calculate Inflation Rate
- McDonald’s Stock: Balancing Value and Innovation
- Overbought Stocks Explained: Should You Trade Them?
- MarketBeat Week in Review – 6/17 – 6/21
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
